Skip to main content
. 2017 Jan 30;19(3):429–435. doi: 10.1111/dom.12844

Figure 1.

Figure 1

Proportion of patients (randomized set) receiving various background anti‐diabetes therapies by racial/ethnic subgroups: A, Caucasians (n=2764); B, Asians (n=2232); C, Japanese (n=645); D, Chinese (n=1005); and E, Indian (n=436). Abbreviations: OAD, oral anti‐diabetes drug; SU, sulphonylurea.